FEMTOPLANE-DoP "FEMTOsecond fibre oscillator PLANar waveguide amplifiEr laser system to enable globally affordable cataract surgery - Development of Prototype"
FEMTOPLANE-DoP "FEMTOsecond fibre oscillator PLANar waveguide amplifiEr laser system to enable globally affordable cataract surgery - Development of Prototype"
批准号:
720759
负责人:
金额:
$22.33万
依托单位:
依托单位国家:
英国
项目类别:
GRD Development of Prototype
财政年份:
2016
资助国家:
英国
项目状态:
已结题
起止时间:
2016 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cataract surgery is one of the most common surgical procedures, with nearly 24 millionprocedures performed worldwide each year. Driven by an ageing population, the annualmarket is growing and is forecast to exceed £1.6 Billion by 2019.Introduced in 2010, Femtosecond laser cataract surgery (FLCS) is regarded to be the mostimportant advancement in technology, enabling procedures to be automated, reducing theneed for skilled surgeons and enabling perfect vision without the need for spectacles orcontact lenses.FLCS is currently dependent on expensive, bulky and unreliable femtosecond laser systemswith price tags ranging from £300K to £370K. FLCS procedures are not supported bynational or private health services and have therefore only been available to the most-wealthypatients.FEMTOPLANE-DoP builds on a highly successful Innovate-UK collaborative R&D projectbetween Fianium and the University of Southampton where the project team proved theconcept of an innovative femtosecond laser architecture, demonstrating specifications farexceeding those required for FLCS yet with potential to be ultra-compact, robust, air-cooledand have low cost of build and ownership.Within FEMTOPLANE-DoP, a fully integrated prototype femtosecond laser will be built andqualified to FLCS specification requirements and will demonstrate up to 85% reduction inprice (volume target £30K) and 80% reduction in size compared to existing state-of-art FLCSlasers.The innovative laser system will be highly disruptive, leading to widespread penetration ofFLCS throughout the world and enabling patients in the poorest countries to benefit from thehighest-quality procedures.Successful delivery of the prototype will be the first commercialisation step towards having amedically qualified laser source in production within 3-4 years of project completion and a20X return on investment by 2020.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
TLR4调控PGK1乳酸化修饰抑制成骨合成代谢驱动DOP的作用及机制
-
批准号:82370893
-
项目类别:面上项目
-
资助金额:48万元
-
批准年份:2023
-
负责人:沈喜妹
-
依托单位:
雌马酚在高糖条件下通过ER途径调控成骨细胞增殖防治DOP的作用和机制研究
-
批准号:81973040
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:王建
-
依托单位:
入侵水华蓝藻-拟柱胞藻对溶解性有机磷酸盐(DOP)的响应及其生态效应研究
-
批准号:31170372
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:吴忠兴
-
依托单位:
脱氧鬼臼毒素(DOP)对美洲大蠊DUM神经元N型乙酰胆碱受体(nAChR)作用机制研究
-
批准号:30971939
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2009
-
负责人:高蓉
-
依托单位:
脱氧鬼臼毒素(DOP)神经毒性电生理及离子通道机制比较研究
-
批准号:30671785
-
项目类别:面上项目
-
资助金额:28.0万元
-
批准年份:2006
-
负责人:高蓉
-
依托单位: